Margherita Ambrosini

10PUBLICATIONS
85CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 24, 2026
Impact on survival of severe immuno-related adverse events in deficient mismatch repair/microsatellite instable-high digestive cancers treated with immunotherapy.

|Dec 22, 2025
ctDNA Detection with Low-Pass Whole-Genome Bisulfite Sequencing in RAS Wild-Type Metastatic Colorectal Cancer: An Exploratory Objective of the VALENTINO Trial.

Paolo Manca, Marta Paoli, Francesca Galardi

|Sep 29, 2025
Neoadjuvant CTLA-4/PD-(L)1 Blockade Versus Surgery +/- Chemotherapy in Deficient Mismatch Repair/Microsatellite Instability-High Resectable Gastroesophageal Adenocarcinoma: Individual Patient Data Pooled Analysis.

Alessandra Raimondi, Gabriele Tinè, Alexej Ballhausen

|Apr 03, 2025
Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancers.

Margherita Ambrosini, Paolo Manca, Vincenzo Nasca

|Jan 04, 2025
Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitors.

Julien Taieb, Margherita Ambrosini, Emily Alouani

|Jul 13, 2023
Transcriptomic Signatures of MSI-High Metastatic Colorectal Cancer Predict Efficacy of Immune Checkpoint Inhibitors.

Claire Gallois, Matteo Landi, Julien Taieb

Pageof 2

Frequent Collaborators

10 joint publications

Filippo Pietrantonio

7 joint publications

Sara Lonardi

6 joint publications

Paolo Manca

4 joint publications

Julien Taieb